Not Medicare Enrolled

Dr. Rafael Beltran Durango, M.D.

Psychiatry · St Petersburg, FL
Low-engagement
3637 4TH ST N, St Petersburg, FL 33704
7278942341
In practice since 2006 (19 years)
NPI: 1093807075 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beltran Durango from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beltran Durango? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beltran Durango

Dr. Rafael Beltran Durango is a psychiatry specialist in St Petersburg, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Beltran Durango received a total of $12,561 from 39 pharmaceutical and/or device companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beltran Durango is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $12,561 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,561
Total received (2018-2024)
Avg $1,794/year across 7 years
Top 7% in FL for psychiatry
39
Companies
529
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,383 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$178 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,076
2023
$2,540
2022
$1,586
2021
$1,311
2020
$1,100
2019
$1,915
2018
$2,033

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$1,614
Takeda Pharmaceuticals U.S.A., Inc.
$923
Lundbeck LLC
$754
ABBVIE INC.
$724
Allergan Inc.
$712
Axsome Therapeutics, Inc.
$694
Alkermes, Inc.
$665
AbbVie Inc.
$605
ITI, Inc.
$603
Sunovion Pharmaceuticals Inc.
$561
IDORSIA PHARMACEUTICALS US INC
$520
Bausch Health US, LLC
$433
Janssen Pharmaceuticals, Inc
$386
Teva Pharmaceuticals USA, Inc.
$364
Neos Therapeutics, LP
$335
JAZZ PHARMACEUTICALS INC.
$314
Allergan, Inc.
$302
Tris Pharma Inc
$254
Eisai Inc.
$243
Supernus Pharmaceuticals, Inc.
$243
Ironshore Pharmaceuticals Inc.
$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$131
Otsuka Pharmaceutical Development & Commercialization, Inc.
$128
Avanir Pharmaceuticals, Inc.
$124
Neurocrine Biosciences, Inc.
$115
Alfasigma USA, Inc.
$113
Neuronetics, Inc.
$93
Corium, LLC
$89
ARBOR PHARMACEUTICALS, INC.
$72
Arbor Pharmaceuticals, Inc.
$62
Shire North American Group Inc
$52
Adlon Therapeutics L.P.
$52
Vanda Pharmaceuticals Inc.
$21
EISAI INC.
$20
Almatica Pharma LLC
$18
Merck Sharp & Dohme Corporation
$18
Noven Therapeutics, LLC
$16
Jazz Pharmaceuticals Inc.
$14
OWP Pharmaceuticals, Inc.
$11
Top 3 companies account for 26.2% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Dayvigo · Dyanavel XR · Evekeo · Evekeo ODT · GRALISE · HETLIOZ · Horizant · INGREZZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · Lamotrigine Starter Kit · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · QELBREE · QUVIVIQ · REXULTI · SPRAVATO · SUNOSI · TRINTELLIX · Trintellix · VIIBRYD · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · XYWAV · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for psychiatry in FL.

Looking for a psychiatry specialist in St Petersburg?
Compare psychiatrists in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
351
Per 100K population
36.5
County median income
$70,293
Nearest hospital
ORLANDO HEALTH BAYFRONT HOSPITAL
1.8 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Beltran Durango is a psychiatry specialist, with low-engagement industry engagement in the top 7% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Beltran Durango receive payments from pharmaceutical companies?
Yes. Dr. Beltran Durango received a total of $12,561 from 39 companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Beltran Durango) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in St Petersburg
Browse psychiatrists in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in FL
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in FL
Which FL psychiatrists receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →